PRMT5 and neoplasm: PRMT5 is known to repress the transcription of critical tumor suppressors by inducing histone H4R3 or H3R8 symmetric di-methylation at the promoter regions of targets (H4R3me2s or H3R8me2s), an event proposed as repressive histone modifications in transcriptional control [39, 40].